Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FOSSA SD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 164 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Skotheim, RI; Kraggerud, SM; Fossa, SD; Stenwig, AE; Gedde-Dahl, T; Danielsen, HE; Jakobsen, KS; Lothe, RA
      Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence

      NEOPLASIA
    2. Rotterud, R; Berner, A; Holm, R; Skovlund, E; Fossa, SD
      p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder

      BJU INTERNATIONAL
    3. Guren, MG; Wiig, JN; Dueland, S; Tveit, KM; Fossa, SD; Waehre, H; Giercksky, KE
      Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    4. de Wit, R; Roberts, JT; Wilkinson, PM; de Mulder, PHM; Mead, GM; Fossa, SD; Cook, P; de Prijck, L; Stenning, S; Collette, L
      Equivalence of three or four cycles of bleomycin, etoposide, and cisplatinchemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: A randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group and the medicalresearch council

      JOURNAL OF CLINICAL ONCOLOGY
    5. Hartmann, JT; Einhorn, L; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Schmoll, HJ; Kanz, L; Bokemeyer, C
      Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis

      JOURNAL OF CLINICAL ONCOLOGY
    6. Sternberg, CN; de Mulder, PHM; Schornagel, JH; Theodore, C; Fossa, SD; van Oosterom, AT; Witjes, F; Spina, M; van Groeningen, CJ; de Balincourt, C; Collette, L
      Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy amd recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancerprotocol no. 30924

      JOURNAL OF CLINICAL ONCOLOGY
    7. Fossa, SD; Slee, PHT; Brausi, M; Horenblas, S; Hall, RR; Hetherington, JW; Aaronson, N; de Prijck, L; Collette, L
      Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: A phase III study of the European Organization for Research and Treatment of Cancer Genitourinary Group

      JOURNAL OF CLINICAL ONCOLOGY
    8. Rotterud, R; Skomedal, H; Berner, A; Danielsen, HE; Skovlund, E; Fossa, SD
      TP53 and p21(WAF1/CIP1) behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy

      ACTA ONCOLOGICA
    9. Lilleby, W; Paus, E; Skovlund, E; Fossa, SD
      Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer

      PROSTATE
    10. Jacobsen, KD; Theodorsen, L; Fossa, SD
      Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy

      JOURNAL OF UROLOGY
    11. Lilleby, W; Torlakovic, G; Torlakovic, E; Skovlund, E; Fossa, SD
      Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy

      CANCER
    12. Bokemeyer, C; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Schmoll, HJ; Kanz, L; Einhorn, L; Nichols, CR; Hartmann, JT
      Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome

      CANCER
    13. Hartmann, JT; Fossa, SD; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Beyer, J; Pont, J; Fizazi, K; Hecker, H; Kanz, L; Einhorn, L; Bokemeyer, C
      Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    14. Hernes, EH; Linja, M; Fossa, SD; Visakorpi, T; Berner, A; Winderen, M; Koivisto, PA
      Hormone-resistant prostate cancer with symptomatic pelvic tumours: patientsurvival and prognostic factors

      BJU INTERNATIONAL
    15. Clobes, H; Fossa, SD; Waehre, H; Jocham, D; Berner, A
      The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy

      BJU INTERNATIONAL
    16. Rapley, EA; Crockford, GP; Teare, D; Biggs, P; Seal, S; Barfoot, R; Edwards, S; Hamoudi, R; Heimdal, K; Fossa, SD; Tucker, K; Donald, J; Collins, F; Friedlander, M; Hogg, D; Goss, P; Heidenreich, A; Ormiston, W; Daly, PA; Forman, D; Oliver, RTD; Leahy, M; Huddart, R; Cooper, CS; Bodmer, JG; Easton, DF; Stratton, MR; Bishop, DT
      Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours

      NATURE GENETICS
    17. Hernandez, AM; Fossa, SD; Brogger, A; Kat, A; Skovlund, E
      Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours

      ANNALS OF ONCOLOGY
    18. Fossa, SD; Skovlund, E
      Interim analyses in clinical trials: Why do we plan them?

      JOURNAL OF CLINICAL ONCOLOGY
    19. Duchesne, GM; Bolger, JJ; Griffiths, GO; Roberts, JT; Graham, JD; Hoskin, PJ; Fossa, SD; Uscinska, BM; Parmar, MKB
      A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: Results of Medical Research Council Trial BA09

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    20. Nord, C; Fossa, SD; Giercksky, KE
      Gastrointestinal presentation of germ cell malignancy

      EUROPEAN UROLOGY
    21. Jacobsen, KD; Fossa, SD
      Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle

      EUROPEAN UROLOGY
    22. Fossa, SD; Curran, D; Aaronson, NK; Keuppens, F; Kliment, J; Robinson, MRG; DeReijke, TM; Hetherington, J; Kil, PJM; Rea, LA
      Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C - Results from the EORTC phase-III Trial 30893

      EUROPEAN UROLOGY
    23. Cappelen, T; Fossa, SD; Stenwig, AE; Aass, N
      False-negative biopsy for testicular intraepithelial neoplasia and high-risk features for testicular cancer

      ACTA ONCOLOGICA
    24. Lilleby, W; Fossa, SD; Knutsen, BH; Abildgaard, A; Skovlund, E; Lien, HH
      Computed tomography/magnetic resonance based volume changes of the primarytumour in patients with prostate cancer with or without androgen deprivation

      RADIOTHERAPY AND ONCOLOGY
    25. Fossa, SD
      Interferon in metastatic renal cell carcinoma

      SEMINARS IN ONCOLOGY
    26. Rorth, M; Meyts, ERD; Andersson, L; Dieckmann, KP; Fossa, SD; Grigor, KM; Hendry, WF; Herr, HW; Looijenga, LHJ; Oosterhuis, JW; Skakkebaek, NE
      Carcinoma in situ in the testis

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    27. Steyerberg, EW; Keizer, HJ; Sleijfer, DT; Fossa, SD; Bajorin, DF; Gerl, A; de Wit, R; Kirkels, WJ; Koops, HS; Habbema, JDF
      Retroperitoneal metastases in testicular cancer: Role of CT measurements of residual masses in decision making for resection after chemotherapy

      RADIOLOGY
    28. Skarstein, J; Aass, N; Fossa, SD; Skovlund, E; Dahl, AA
      Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire

      JOURNAL OF PSYCHOSOMATIC RESEARCH
    29. Hartmann, JT; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Einhorn, L; Kanz, L; Bokemeyer, C
      The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors

      CANCER
    30. Fossa, A; Siebert, R; Aasheim, HC; Maelandsmo, GM; Berner, A; Fossa, SD; Paus, E; Smeland, EB; Gaudernack, G
      Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

      BRITISH JOURNAL OF CANCER
    31. Horwich, A; Oliver, RTD; Wilkinson, PM; Mead, GM; Harland, SJ; Cullen, MH; Roberts, JT; Fossa, SD; Dearnaley, DP; Lallemand, E; Stenning, SP
      A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma

      BRITISH JOURNAL OF CANCER
    32. Fossa, SD; Kravdal, O
      Fertility in Norwegian testicular cancer patients

      BRITISH JOURNAL OF CANCER
    33. Hartmann, JT; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Fizazi, K; Einhorn, L; Kanz, L; Bokemeyer, C
      Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    34. Fossa, SD; Opjordsmoen, S; Haug, E
      Androgen replacement and quality of life in patients treated for bilateraltesticular cancer

      EUROPEAN JOURNAL OF CANCER
    35. Kraggerud, SM; Berner, A; Bryne, M; Pettersen, EO; Fossa, SD
      Spermatocytic seminoma as compared to classical seminoma: An immunohistochemical and DNA flow cytometric study

      APMIS
    36. Fossa, SD; Horwich, A; Russell, JM; Roberts, JT; Cullen, MH; Hodson, NJ; Jones, WG; Yosef, H; Duchesne, GM; Owen, JR; Grosch, EJ; Chetiyawardana, AD; Reed, NS; Widmer, B; Stenning, SP
      Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial

      JOURNAL OF CLINICAL ONCOLOGY
    37. Lilleby, W; Fossa, SD; Waehre, HR; Olsen, DR
      Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    38. Dale, E; Olsen, DR; Fossa, SD
      Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    39. Ogreid, P; Berner, A; Dahl, O; Rettedal, E; Fossa, SD
      Tissue prostate-specific antigen and androgen receptor immunoreactivity inprostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy

      EUROPEAN UROLOGY
    40. Litwin, MS; Fitzpatrick, JM; Fossa, SD; Newling, DWW
      Defining an international research agenda for quality of life in men with prostate cancer

      PROSTATE
    41. Lilleby, W; Olsen, DR; Fossa, SD
      Comparison of radiation side-effects in prostate cancer

      LANCET
    42. Ritchie, A; Griffiths, G; Parmar, M; Fossa, SD; Selby, PJ; Cornbleet, MA; Sibley, G; Mead, GM; Kaye, S; Owen, JR; Oliver, RTD; Smith, PH; Whelan, P; Cook, PA; Fayers, PM; Cook, P; Webb, J; Whitehead, J; Lamont, A
      Interferon-alpha and survival in metastatic renal carcinoma: early resultsof a randomised controlled trial

      LANCET
    43. Fossa, SD
      Good quality of life in prostate cancer patients - How can it be obtained?

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    44. Fossa, SD; Bokemeyer, C; Gerl, A; Culine, S; Jones, WG; Mead, GM; Germa-Luch, JR; Pont, J; Schmoll, HJ; Tjulandin, S
      Treatment outcome of patients with brain metastases from malignant germ cell tumors

      CANCER
    45. Fossa, SD; Stenning, SP; Gerl, A; Horwich, A; Clark, PI; Wilkinson, PM; Jones, WG; Williams, MV; Oliver, RT; Newlands, ES; Mead, GM; Cullen, MH; Kaye, SB; Rustin, GJS; Cook, PA
      Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours

      BRITISH JOURNAL OF CANCER
    46. Jacobsen, KD; Ous, S; Waehre, H; Trasti, H; Stenwig, AE; Lien, HH; Aass, N; Fossa, SD
      Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection

      BRITISH JOURNAL OF CANCER
    47. Collette, L; Sylvester, RJ; Stenning, SP; Fossa, SD; Mead, GM; de Wit, R; de Mulder, PHM; Neymark, N; Lallemand, E; Kaye, SB
      Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    48. LILLEBY W; FOSSA SD; WAEHRE HR; OLSEN DR
      LONG-TERM MORBIDITY AND QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LOCALIZED PROSTATE-CANCER UNDERGOING DEFINITIVE RADIOTHERAPY OR RADICAL PROSTATECTOMY

      Psycho-oncology
    49. FOSSA SD; AASS N; PARO G
      A PHASE-II STUDY OF DAUNOXOME(R) IN ADVANCED UROTHELIAL TRANSITIONAL-CELL CARCINOMA

      European journal of cancer
    50. BOFFETTA P; FICHTINGERSCHEPMAN AMJ; WEIDERPASS E; VANDIJKKNIJNENBURG HCM; STOTER G; VANOOSTEROM AT; KEIZER HJ; FOSSA SD; KALDOR J; ROY P
      CISPLATIN - DNA-ADDUCTS AND PROTEIN-BOUND PLATINUM IN BLOOD OF TESTICULAR CANCER-PATIENTS

      Anti-cancer drugs
    51. Wanderas, EH; Grotmol, T; Fossa, SD; Tretli, S
      Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995

      CANCER CAUSES & CONTROL
    52. HARTMANN JT; NICHOLS CR; DROZ JP; HORWICH A; GERL A; FOSSA SD; BEYER J; PONT J; SCHMOLL HJ; BOKEMEYER C
      EXTRAGONADAL GERM-CELL TUMORS (EGGCT) AND HEMATOLOGIC DISORDERS - INCIDENCE AND OUTCOME FROM AN INTERNATIONAL DATABASE

      Annals of oncology
    53. RAPLEY E; TUCKER K; COLLINS F; DONALD J; FRIEDLANDER M; PENG HQ; GOSS P; HOGG D; EASTON DF; TEARE D; BISHOP DT; CROCKFORD G; FORMAN D; LEAHY M; BODMER JG; MOSES J; TONKS S; OLIVER RTD; BIGGS P; SEAL S; BARFOOT R; GILL S; PATEL S; HAMOUDI R; HUNTER R; THOMLINSON I; COOPER C; STRATTON M; HUDDART R; FOSSA SD; HEIMDAL K
      CANDIDATE REGIONS FOR TESTICULAR CANCER SUSCEPTIBILITY GENES

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    54. FOSSA SD; KAYE SB; MEAD GM; CULLEN M; DEWIT R; BODROGI I; VANGROENINGEN CJ; DEMULDER PHM; STENNING S; LALLEMAND E; DEPRIJCK L; COLLETTE L
      FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY

      Journal of clinical oncology
    55. STEYERBERG EW; GERL A; FOSSA SD; SLEIJFER DT; DEWIT R; KIRKELS WJ; SCHMELLER N; CLEMM C; HABBEMA JDF; KEIZER HJ
      VALIDITY OF PREDICTIONS OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY INNONSEMINOMATOUS TESTICULAR CANCER

      Journal of clinical oncology
    56. ILNER K; BLOMLIE V; FOSSA SD
      RADIATION-INDUCED INSUFFICIENCY FRACTURES AFTER DEFINITIVE PROSTATE-CANCER RADIOTHERAPY

      Acta oncologica
    57. FOSSA SD; FOSSABRAHAMSEN A; NOME O
      SEMEN QUALITY AFTER TREATMENT FOR HODGKIN,M. AND TESTICULAR CANCER

      Human reproduction (Oxford. Print)
    58. HARLAND SJ; COOK PA; FOSSA SD; HORWICH A; MEAD GM; PARKINSON MC; ROBERTS JT; STENNING SP
      INTRATUBULAR GERM-CELL NEOPLASIA OF THE CONTRALATERAL TESTIS IN TESTICULAR CANCER - DEFINING A HIGH-RISK GROUP

      The Journal of urology
    59. PAUS E; NILSSON O; BORMER OP; FOSSA SD; OTNES B; SKOVLUND E
      STABILITY OF FREE AND TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM FROM PATIENTS WITH PROSTATE CARCINOMA AND BENIGN HYPERPLASIA

      The Journal of urology
    60. AVIZIENYTE E; ROTH S; LOUKOLA A; HEMMINKI A; LOTHE RA; STENWIG AE; FOSSA SD; SALOVAARA R; AALTONEN LA
      SOMATIC MUTATIONS IN LKB1 ARE RARE IN SPORADIC COLORECTAL AND TESTICULAR-TUMORS

      Cancer research
    61. STENNING SP; PARKINSON MC; FISHER C; MEAD GM; COOK PA; FOSSA SD; HORWICH A; JONES WG; NEWLANDS ES; OLIVER RT; STENWIG AE; WILKINSON PM
      POSTCHEMOTHERAPY RESIDUAL MASSES IN GERM-CELL TUMOR PATIENTS - CONTENT, CLINICAL-FEATURES, AND PROGNOSIS

      Cancer
    62. OSEN I; FOSSA SD; MAJAK B; ROTTERUD R; BERNER A
      PROGNOSTIC FACTORS IN MUSCLE-INVASIVE BLADDER-CANCER TREATED WITH RADIOTHERAPY - AN IMMUNOHISTOCHEMICAL STUDY

      British Journal of Urology
    63. DUELAND S; STENWIG AE; HEILO A; HOIE J; OUS S; FOSSA SD
      TREATMENT AND OUTCOME OF PATIENTS WITH EXTRAGONADAL GERM-CELL TUMORS - THE NORWEGIAN RADIUM HOSPITALS EXPERIENCE 1979-94

      British Journal of Cancer
    64. FOSSA SD; OLIVER RTD; STENNING SP; HORWICH A; WILKINSON P; READ G; MEAD GM; ROBERTS JT; RUSTIN G; CULLEN MH; KAYE SB; HARLAND SJ; COOK P
      PROGNOSTIC FACTORS FOR PATIENTS WITH ADVANCED SEMINOMA TREATED WITH PLATINUM-BASED CHEMOTHERAPY

      European journal of cancer
    65. DUCHESNE GM; STENNING SP; AASS N; MEAD GM; FOSSA SD; OLIVER RTD; HORWICH A; READ G; ROBERTS IT; RUSTIN G; CULLEN MH; KAYE SB; HARLAND SJ; COOK PA
      RADIOTHERAPY AFTER CHEMOTHERAPY FOR METASTATIC SEMINOMA - A DIMINISHING ROLE

      European journal of cancer
    66. DEWIT R; PAWINSKY A; STOTER G; VANOOSTEROM AT; FOSSA SD; PARIDAENS R; SVEDBERG A; DEMULDER PHM
      EORTC PHASE-II STUDY OF DAILY ORAL LINOMIDE IN METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH GOOD PROGNOSTIC FACTORS

      European journal of cancer
    67. FOSSA SD; HORWICH A
      CURRENT STATUS OF CHEMOTHERAPY IN ADVANCED SEMINOMA

      European journal of cancer
    68. WANDERAS EH; FOSSA SD; TRETLI S
      RISK OF A 2ND GERM-CELL CANCER AFTER TREATMENT OF A PRIMARY GERM-CELLCANCER IN 2201 NORWEGIAN MALE-PATIENTS

      European journal of cancer
    69. WANDERAS EH; FOSSA SD; TRETLI S
      RISK OF SUBSEQUENT NON-GERM CELL-CANCER AFTER TREATMENT OF GERM-CELL CANCER IN 2006 NORWEGIAN MALE-PATIENTS

      European journal of cancer
    70. AASS N; FOSSA SD; DAHL AA; MOE TJ
      PREVALENCE OF ANXIETY AND DEPRESSION IN CANCER-PATIENTS SEEN AT THE NORWEGIAN-RADIUM-HOSPITAL

      European journal of cancer
    71. FOSSA SD
      CURRENT POSITION OF CYTOKINES IN THE CLINICAL ONCOLOGY OF SOLID TUMORS

      European journal of cancer
    72. HERLOFSON BB; NORMANPEDERSEN K; REDFORS M; FOSSA SD
      ORAL MUCOSAL SIDE-EFFECTS OF CYTOTOXIC CHEMOTHERAPY OF TESTICULAR CANCER - A RETROSPECTIVE STUDY

      European journal of oral sciences
    73. HORWICH A; SLEIJFER DT; FOSSA SD; KAYE SB; OLIVER RTD; CULLEN MH; MEAD GM; DEWIT R; DEMULDER PHM; DEARNALEY DP; COOK PA; SYLVESTER RJ; STENNING SP
      RANDOMIZED TRIAL OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN COMPARED WITHBLEOMYCIN, ETOPOSIDE, AND CARBOPLATIN IN GOOD-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL CANCER - A MULTIINSTITUTIONAL MEDICAL-RESEARCH-COUNCIL -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER TRIAL

      Journal of clinical oncology
    74. MEAD GM; STENNING SP; COOK P; FOSSA SD; HORWICH A; KAYE SB; OLIVER RTD; DEMULDER PHM; DEWIT R; STOTER G; SYLVESTER RJ; BAJORIN DF; BOSL GJ; MAZUMDAR M; NICHOLS CR; AMATO R; PIZZOCARO G; DROZ JP; KRAMAR A; DAUGAARD G; CORTESFUNES H; PAZARES L; LEVI JA; COLLS BM; HARVEY VJ; COPPIN C
      INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS

      Journal of clinical oncology
    75. JACOBSEN KD; OLSEN DR; FOSSA K; FOSSA SD
      EXTERNAL-BEAM ABDOMINAL RADIOTHERAPY IN PATIENTS WITH SEMINOMA STAGE-I - FIELD TYPE, TESTICULAR DOSE, AND SPERMATOGENESIS

      International journal of radiation oncology, biology, physics
    76. KRAGGERUD SM; JACOBSEN KD; BERNER A; STOKKE T; HOLM R; SMEDSHAMMER L; BORRESENDALE AL; FOSSA SD
      A COMPARISON OF DIFFERENT MODES FOR THE DETECTION OF P53 PROTEIN ACCUMULATION - A STUDY OF BLADDER-CANCER

      Pathology research and practice
    77. HOLLENDER A; STENWIG EA; OUS S; FOSSA SD
      SURVIVAL OF PATIENTS WITH VIABLE MALIGNANT NONSEMINOMATOUS GERM-CELL TUMOR PERSISTENT AFTER CISPLATIN-BASED INDUCTION CHEMOTHERAPY

      European urology
    78. FOSSA SD; WOEHRE H; KURTH KH; HETHERINGTON J; BAKKE H; RUSTAD DA; SKANVIK R
      INFLUENCE OF UROLOGICAL MORBIDITY ON QUALITY-OF-LIFE IN PATIENTS WITHPROSTATE-CANCER

      European urology
    79. RAABE NK; KAARESEN R; FOSSA SD
      ANALYSIS OF ADJUVANT TREATMENT IN POSTMENOPAUSAL PATIENTS WITH STAGE-II INVASIVE BREAST-CARCINOMA - A PATTERN OF CARE STUDY AND QUALITY ASSURANCE OF 431 CONSECUTIVE PATIENTS IN OSLO 1980-1989

      Acta oncologica
    80. FOSSA SD
      RESIDUAL ANDROGEN DEPENDING IN HORMONE-RESISTANT PROSTATE-CANCER

      Acta oncologica
    81. FOSSA SD; DEANGELIS P; KRAGGERUD SM; EVENSON D; THEODORSEN L; CLAUSEN OPF
      PREDICTION OF POSTTREATMENT SPERMATOGENESIS IN PATIENTS WITH TESTICULAR CANCER BY FLOW CYTOMETRIC SPERM CHROMATIN STRUCTURE ASSAY

      Cytometry
    82. AASS N; HATUN DE; THORESEN M; FOSSA SD
      PROPHYLACTIC USE OF TROPISETRON OR METOCLOPRAMIDE DURING ADJUVANT ABDOMINAL RADIOTHERAPY OF SEMINOMA STAGE-I - A RANDOMIZED, OPEN TRIAL IN 23 PATIENTS

      Radiotherapy and oncology
    83. NEWLING D; FOSSA SD; ANDERSSON L; ABRAHAMSSON PA; ASO Y; EISENBERGER MA; KHOURY S; KOZLOWSKI JS; KELLY K; SCHER H; HARTLEYASP B
      ASSESSMENT OF HORMONE-REFRACTORY PROSTATE-CANCER

      Urology
    84. STEYERBERG EW; DONOHUE JP; GERL A; TONER GC; KOOPS HS; FOSSA SD; KEIZER HJ
      RESIDUAL MASSES AFTER CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER -THE CLINICAL IMPLICATIONS OF THE ASSOCIATION BETWEEN RETROPERITONEAL AND PULMONARY HISTOLOGY

      The Journal of urology
    85. STEYERBERG EW; KEIZER HJ; MESSEMER JE; TONER GC; KOOPS HS; FOSSA SD; GERL A; SLEIJFER DT; DONOHUE JP; HABBEMA KDF
      RESIDUAL PULMONARY MASSES AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - PREDICTION OF HISTOLOGY

      Cancer
    86. HERNES EH; FOSSA SD; VAAGE S; OGREID P; HEILO A; PAUS E
      EPIRUBICIN COMBINED WITH ESTRAMUSTINE PHOSPHATE IN HORMONE-RESISTANT PROSTATE-CANCER - A PHASE-II STUDY

      British Journal of Cancer
    87. HEIMDAL K; OLSSON H; TRETLI S; FOSSA SD; BORRESEN AL; BISHOP DT
      A SEGREGATION ANALYSIS OF TESTICULAR CANCER BASED ON NORWEGIAN AND SWEDISH FAMILIES

      British Journal of Cancer
    88. LORAAS A; FOSSA SD; FRANZEN S; SAETER G; RODE L
      SKIN-LESIONS AND G-CSF IN PATIENTS WITH MALIGNANT DISEASES - MALIGNANCY OR CUTANEOUS SIDE-EFFECT

      European journal of cancer
    89. DASILVA FC; FOSSA SD; AARONSON NK; SERBOUTI S; DENIS L; CASSELMAN J; WHELAN P; HETHERINGTON J; FAVA C; RICHARDS B; ROBINSON MRG
      THE QUALITY-OF-LIFE OF PATIENTS WITH NEWLY-DIAGNOSED M1 PROSTATE-CANCER - EXPERIENCE WITH EORTC CLINICAL-TRIAL-30853

      European journal of cancer
    90. FOSSA SD; MOYNIHAN C; SERBOUTI S
      PATIENTS AND DOCTORS PERCEPTION OF LONG-TERM MORBIDITY IN PATIENTS WITH TESTICULAR CANCER CLINICAL STAGE-I - A DESCRIPTIVE PILOT-STUDY

      Supportive care in cancer
    91. CULLEN MH; STENNING SP; PARKINSON MC; FOSSA SD; KAYE SB; HORWICH AH; HARLAND SJ; WILLIAMS MV; JAKES R
      SHORT-COURSE ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - A MEDICAL-RESEARCH-COUNCIL REPORT

      Journal of clinical oncology
    92. HERNES EH; HARSTAD K; FOSSA SD
      CHANGING INCIDENCE AND DELAY OF TESTICULAR CANCER IN SOUTHERN NORWAY (1981-1992)

      European urology
    93. BERNER A; SKJORTEN FJ; FOSSA SD
      FOLLOW-UP OF PROSTATIC INTRAEPITHELIAL NEOPLASIA

      European urology
    94. FOSSA SD
      QUALITY-OF-LIFE IN PROSTATE-CANCER - WHAT ARE THE ISSUES AND HOW ARE THEY MEASURED

      European urology
    95. FOSSA SD; AASS N; OUS S; WAEHRE H; ILNER K; HANNISDAL E
      SURVIVAL AFTER CURATIVE TREATMENT OF MUSCLE-INVASIVE BLADDER-CANCER

      Acta oncologica
    96. FOSSA SD
      QUALITY-OF-LIFE IN ADVANCED PROSTATE-CANCER

      Seminars in oncology
    97. PARKINSON MC; FISHER C; STENNING SP; COOK P; FOSSA SD; HORWICH A; MEAD GM; NESLAND J; OLIVER RTD; STENWIG AE
      RESIDUAL MASSES POSTCHEMOTHERAPY FOR GERM-CELL TUMOR (GCT) - CONTENT,CLINICAL-FEATURES AND PROGNOSIS - BRITISH MRC STUDY

      Laboratory investigation
    98. PARKINSON MC; STENNING SP; COOK P; HARLAND SJ; FOSSA SD; ROBERTS JT; HORWICH A; MEAD GM
      TESTICULAR GCTS AND CONTRALATERAL CIS - BRITISH MRC STUDY

      Laboratory investigation
    99. MALMSTROM PU; RINTALA E; WAHLQVIST R; HELLSTROM P; HELLSTEN S; HANNISDAL E; ALFTHAN O; RUSK J; OPAS MA; JAUHIAINEN K; OTTELIN J; PERMI J; SALMELA H; TAINIO H; TALJA M; TUHKANEN K; VIITANEN J; BREVIK B; HOEG OM; JOHANNESSEN NB; FARSUND T; MEDBY PC; MURI O; FOSSA SD; OUS S; SANDER S; TVETER KJ; OMLAND H; STEINSVIK E; URNES T; WAALER G; OGREID P; OSTREM T; ANDERSSON L; EDSMYR F; EKMAN P; GUSTAFSON H; NORMING U; WIJKSTROM H; KARLBERG L; KIHL B; LINDEBORG T
      5-YEAR FOLLOW-UP OF A PROSPECTIVE TRIAL OF RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY - NORDIC CYSTECTOMY TRIAL-I

      The Journal of urology
    100. BRAENDENGEN M; WINDEREN M; FOSSA SD
      CLINICAL-SIGNIFICANCE OF ROUTINE PRE-CYSTECTOMY BONE SCANS IN PATIENTS WITH MUSCLE-INVASIVE BLADDER-CANCER

      British Journal of Urology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 18:44:09